Simvastatin treatment significantly inhibited transcript levels of LRP6 (1.69‐fold), AXIN2 (3.33‐fold) and Cyclin D1 (1.59‐fold) (Figure 7G), while we found a higher expression of the tumour suppressor APC levels compared to control. The gene discussed is LRP6; the disease is neoplasm.